2023, Vol. 7 Issue 2, Part APages: 38-41
Clinical assessment of Mizaj (Temperament) in the patients of Subclinical Hypothyroidism
Irshad, Rais Ur Rahman, Nasir Jamal and Nida Choudhary
Viewed: 28 - Downloaded: 10
Hippocrates was the first to put forward the Mizaj (temperament) school of thought. The Unani medical system is the only one to use the principle of Mizaj (temperament), and the system is built around this central idea. In accordance with this theory, Hippocrates (460–370 BC), the father of medicine and the creator of the Unani School of medicine, each individual has a unique Mizaj (temperament) that is fixed and cannot be altered. Every individual has unique preferences, dislikes, hobbies, skills, and tastes. The sum of all these qualities constitutes a person's superior temperament, or Mizaj (temperament). It has an immediate effect on a person's health and susceptibility to disease. Four kinds of Mizaj (temperament) have been developed by Unani doctors: Damvi (sanguine), Balghami (phlegmatic), Safravi (bilious), and Saudavi (melancholic). Subclinical hypothyroidism is a state in which t3 & t4 are within normal range but TSH is elevated and its signs and symptoms mostly resemble the sue mizaj balghami. Evaluation and analysis of the Mizaj (temperament) of patients with subclinical hypothyroidism were the study's main goals. The results of this study, based on the conventional understanding of temperament, offer hope for preventing and treating subclinical hypothyroidism. 40 participants who met the inclusion and exclusion criteria and had a verified biochemical diagnosis of subclinical hypothyroidism were enrolled in the trial at A & U Tibbia College in Karol Bagh, New Delhi-05. A typical temperament test was used to assess the Mizaj of the subjects. In the current observational study, Balghami (phlegmatic) Mizaj had a greater incidence of patients. The patient's temperament (Mizaj), which was examined in accordance with traditional Unani literature, may have a significant impact on the emergence and progression of subclinical hypothyroidism.